3DPrint.com January 12, 2024
Vanesa Listek

Navigating through the landscape of bioprinting, 2023 unfolded as a year where targeted investments significantly nurtured this specialized field. The ripples of these investments indicate a maturing industry poised for growth. This year’s investment trend in bioprinting was marked by a series of strategic moves aimed at deepening the potential of bioprinting in medical applications.

The investments in 2023 primarily came from public or government sectors, with notable contributions from private entities. A common thread among these investments is their focus on innovative applications in healthcare, aiming to bridge the gap between advanced research and practical medical solutions. From ambitious projects aiming to revolutionize organ transplantation to more focused studies enhancing specific medical treatments, each funding initiative reflected a concerted...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Biotechnology, Investments, Pharma / Biotech, Technology, Trends
Technologies Transforming the Surgical Experience
WASP Highlights Advances in Healthcare 3D Printing at Italy’s Exposanità 2024
3D Systems Brings 3D Printed PEEK Cranial Implant to the U.S. with FDA Clearance
3D Printing Market Hits $14.7B Amid Challenges in 2023
World’s First Bioprinted Trachea Transplant Marks a New Era in Medical Innovation

Share This Article